Financial News
Opus Genetics, Inc. - Common Stock (NQ:IRD)
Price and Volume
Detailed Quote| Volume | 1,304,093 |
| Open | 5.350 |
| Bid (Size) | 5.000 (100) |
| Ask (Size) | 5.230 (200) |
| Prev. Close | 5.360 |
| Today's Range | 4.850 - 5.360 |
| 52wk Range | 0.9011 - 5.810 |
| Shares Outstanding | 20,579,779 |
| Dividend Yield | N/A |
Top News
More News
Wondering what's happening in today's after-hours session? ↗
December 31, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
November 07, 2025
Performance
More News
Read More
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 06, 2025
Unusual volume stocks in Tuesday's session ↗
June 03, 2025
Discover the top movers in Friday's pre-market session. ↗
March 21, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
March 18, 2025
Frequently Asked Questions
Is Opus Genetics, Inc. - Common Stock publicly traded?
Yes, Opus Genetics, Inc. - Common Stock is publicly traded.
What exchange does Opus Genetics, Inc. - Common Stock trade on?
Opus Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Opus Genetics, Inc. - Common Stock?
The ticker symbol for Opus Genetics, Inc. - Common Stock is IRD on the Nasdaq Stock Market
What is the current price of Opus Genetics, Inc. - Common Stock?
The current price of Opus Genetics, Inc. - Common Stock is 4.990
When was Opus Genetics, Inc. - Common Stock last traded?
The last trade of Opus Genetics, Inc. - Common Stock was at 05/08/26 04:00 PM ET
What is the market capitalization of Opus Genetics, Inc. - Common Stock?
The market capitalization of Opus Genetics, Inc. - Common Stock is 102.69M
How many shares of Opus Genetics, Inc. - Common Stock are outstanding?
Opus Genetics, Inc. - Common Stock has 103M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
